EverSource Wealth Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

EverSource Wealth Advisors’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Sell	1,462 -744	-34%	-$27K	﹤0.01%	1657
2026 Q1	$67.2K	Buy	2,206 +1,472	+201%	+$48.6K	﹤0.01%	1678
2025 Q4	$26.3K	Buy	734 +687	+1,462%	+$21K	﹤0.01%	2202
2025 Q3	$1.13K	Buy	+47	New	+$984	﹤0.01%	3729
2025 Q1	–	Sell	-252	Closed	-$3.13K	–	4100
2024 Q4	$3.13K	Hold	252	–	–	﹤0.01%	2542
2024 Q3	$2.46K	Hold	252	–	–	﹤0.01%	2477
2024 Q2	$3.46K	Hold	252	–	–	﹤0.01%	2347
2024 Q1	$4.42K	Buy	+252	New	+$4.73K	﹤0.01%	2100

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

EverSource Wealth Advisors's INDV Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Indivior Pharmaceuticals (INDV) stake by 34% in Q2 2026, selling an estimated $27K and leaving 1,462 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

EverSource Wealth Advisors first reported a position in INDV in Q1 2024 and has held it in 8 quarters since. The position peaked at $67.2K in Q1 2026. 49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

EverSource Wealth Advisors held 1,462 shares of Indivior Pharmaceuticals worth $60K as of Q2 2026.
EverSource Wealth Advisors sold 744 Indivior Pharmaceuticals shares in Q2 2026, an estimated $27K.
Indivior Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1657 holding.
EverSource Wealth Advisors first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
EverSource Wealth Advisors's Indivior Pharmaceuticals position peaked at $67.2K in Q1 2026.
49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.